Effects of phycocyanin on INS-1 pancreatic β-cell mediated by PI3K/Akt/FoxO1 signaling pathway

International Journal of Biological Macromolecules

Volumn 83, Issue , 2016, Pages 185-194

  Gao, Yingnv ^a   Liao, Gaoyong ^a   Xiang, Chenxi ^a   Yang, Xuegan ^a   Cheng, Xiaodong ^b   Ou, Yu ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Akt; FoxO1; Methylglyoxal; Phycocyanin; Cell dysfunction

Indexed keywords

INSULIN; METHYLGLYOXAL; PHYCOCYANIN; PROTEIN KINASE; RNA; TRANSCRIPTION FACTOR FKHR; WORTMANNIN; ANTIDIABETIC AGENT; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, RAT; NERVE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWNSTREAM PROCESSING; HUMAN; INSULIN RELEASE; INSULINOMA; MOLECULAR MECHANICS; NUCLEAR LOCALIZATION SIGNAL; PANCREAS ISLET BETA CELL; PROTEIN DEPHOSPHORYLATION; RNA INTERFERENCE; TRANSACTIVATION; ANIMAL; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; INTRACELLULAR SPACE; METABOLISM; PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; FORKHEAD TRANSCRIPTION FACTORS; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; INTRACELLULAR SPACE; NERVE TISSUE PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PHYCOCYANIN; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; PYRUVALDEHYDE; RATS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 84949895803     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2015.11.054     Document Type: Article

References (43)

1. Dandona P., Aljada A., Chaudhuri A., Mohanty P., Garg R. Metabolic syndrome a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005, 111:1448-1454.
2. Cai W., Ramdas M., Zhu L., Chen X., Striker G.E., Vlassara H. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:15888-15893.
3. Vlassara H., Striker G.E. AGE restriction in diabetes mellitus: a paradigm shift. Nat. Rev. Endocrinol. 2011, 7:526-539.
4. Thornalley P.J. Endogenous alpha-oxoaldehydes and formation of protein and nucleotide advanced glycation endproducts in tissue damage. Novartis Found. Symp. 2007, 229. John Wiley, Chichester/New York.
5. Fiory F., Lombardi A., Miele C., Giudicelli J., Beguinot F., Van Obberghen E. Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E. Diabetologia 2011, 54:2941-2952.
6. Riboulet-Chavey A., Pierron A., Durand I., Murdaca J., Giudicelli J., Van Obberghen E. Methylglyoxal impairs the insulin signaling pathways independently of the formation of intracellular reactive oxygen species. Diabetes 2006, 55:1289-1299.
7. Cook L., Davies J., Yates A., Elliott A., Lovell J., Joule J., Pemberton P., Thornalley P., Best L. Effects of methylglyoxal on rat pancreatic β-cells. Biochem. Pharmacol. 1998, 55:1361-1367.
8. Sheader E.A., Benson R.S., Best L. Cytotoxic action of methylglyoxal on insulin-secreting cells. Biochem. Pharmacol. 2001, 61:1381-1386.
9. Dhar A., Dhar I., Jiang B., Desai K.M., Wu L. Chronic methylglyoxal infusion by minipump causes pancreatic β-cell dysfunction and induces type 2 diabetes in Sprague-Dawley rats. Diabetes 2011, 60:899-908.
10. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C. β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
11. Dearth R.K., Cui X., Kim H.-J., Hadsell D.L., Lee A.V. Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2. Cell Cycle 2007, 6:705-713.
12. 2+ stores in insulin-stimulated insulin secretion in β-cells. J. Biol. Chem. 2000, 275:22331-22338.
13. Watanabe H., Saito H., Ueda J., Evers B.M. Regulation of pancreatic duct cell differentiation by phosphatidylinositol-3 kinase. Biochem. Biophys. Res. Commun. 2008, 370:33-37.
14. Liang J., Slingerland J.M. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2003, 2:336-342.
15. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell. Biol. 2006, 7:85-96.
16. Martinez S.C., Tanabe K., Cras-Méneur C., Abumrad N.A., Bernal-Mizrachi E., Permutt M.A. Inhibition of Foxo1 protects pancreatic islet β-cells against fatty acid and endoplasmic reticulum stress-induced apoptosis. Diabetes 2008, 57:846-859.
17. Buteau J., Spatz M.L., Accili D. Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic β-cell mass. Diabetes 2006, 55:1190-1196.
18. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
19. Nemoto S., Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 2002, 295:2450-2452.
20. Qiang L., Banks A.S., Accili D. Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization. J. Biol. Chem. 2010, 285:27396-27401.
21. Kim S.-J., Winter K., Nian C., Tsuneoka M., Koda Y., McIntosh C.H. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic β-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J Biol. Chem. 2005, 280:22297-22307.
22. Ou Y., Lin L., Yang X., Pan Q., Cheng X. Antidiabetic potential of phycocyanin: effects on KKAy mice. Pharm. Biol. 2013, 51:539-544.
23. Ou Y., Lin L., Pan Q., Yang X., Cheng X. Preventive effect of phycocyanin from Spirulina platensis on alloxan-injured mice. Environ. Toxicol. Phar. 2012, 34:721-726.
24. Madhyastha H.K., Radha K.S., Sugiki M., Omura S., Maruyama M. Purification of c-phycocyanin from Spirulina fusiformis and its effect on the induction of urokinase-type plasminogen activator from calf pulmonary endothelial cells. Phytomedicine 2006, 13:564-569.
25. Meng Z.X., Nie J., Ling J.J., Sun J.X., Zhu Y.X., Gao L., Lv J.H., Zhu D.Y., Sun Y.J., Han X. Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest. Diabetologia 2009, 52:125-135.
26. Kaiser G., Gerst F., Michael D., Berchtold S., Friedrich B., Strutz-Seebohm N., Lang F., Haring H.U., Ullrich S. Regulation of forkhead box O1 (FOXO1) by protein kinase B and glucocorticoids: different mechanisms of induction of beta cell death in vitro. Diabetologia 2013, 56:1587-1595.
27. Mishra T., Khullar M., Bhatia A. Anticancer potential of aqueous ethanol seed extract of Ziziphus mauritiana against cancer cell lines and Ehrlich Ascites Carcinoma. Evid. Based Complement Altern. Med.: eCAM 2011, 2011.
28. Okamoto H., Nakae J., Kitamura T., Park B.C., Dragatsis I., Accili D. Transgenic rescue of insulin receptor-deficient mice. J. Clin. Invest. 2004, 114:214-223.
29. Shao S., Nie M., Chen C., Chen X., Zhang M., Yuan G., Yu X., Yang Y. Protective action of liraglutide in beta cells under lipotoxic stress via PI3K/Akt/FoxO1 pathway. J. Cell. Biochem. 2014, 115:1166-1175.
30. Glazer A.N. Directional energy transfer in a photosynthetic antenna. J. Biol. Chem. 1989, 264:1-4.
31. Hughes K.J., Meares G.P., Hansen P.A., Corbett J.A. FoxO1 and SIRT1 regulate β-cell responses to nitric oxide. J. Biol. Chem. 2011, 286:8338-8348.
32. Gross D., van den Heuvel A., Birnbaum M. The role of FoxO in the regulation of metabolism. Oncogene 2008, 27:2320-2336.
33. Meng Z.X., Sun J.X., Ling J.J., Lv J.H., Zhu D.Y., Chen Q., Sun Y.J., Han X. Prostaglandin E2 regulates Foxo activity via the Akt pathway: implications for pancreatic islet beta cell dysfunction. Diabetologia 2006, 49:2959-2968.
34. Kawamori D., Kaneto H., Nakatani Y., Matsuoka T.-A., Matsuhisa M., Hori M., Yamasaki Y. The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J. Biol. Chem. 2006, 281:1091-1098.
35. Bo J.S., Xie S.Y., Guo Y., Zhang C.L., Guan Y.M., Li C.M., Lu J.X., Meng Q.H. Methylglyoxal impairs insulin secretion of pancreatic β-cells through increased production of ROS and mitochondrial dysfunction mediated by upregulation of UCP2 and MAPKs. J. Diabetes Res. 2015, Article ID 239380, in press.
36. Li X.L., Chen T., Wong Y.S., Xu G., Fan R.R., Zhao H.L., Chan J.C. Involvement of mitochondrial dysfunction in human islet amyloid polypeptide-induced apoptosis in INS-1E pancreatic beta cells: an effect attenuated by phycocyanin. Int. J. Biochem. Cell B. 2011, 43:525-534.
37. Zheng J., Inoguchi T., Sasaki S., Maeda Y., McCarty M.F., Fujii M., Ikeda N., Kobayashi K., Sonoda N., Takayanagi R. Phycocyanin and phycocyanobilin from Spirulina platensis protect against diabetic nephropathy by inhibiting oxidative stress. Am. J. Physiol-Reg. I 2013, 304:R110-R120.
38. ZHANG R., MA X., LIU L. Effect of phycocyanin on the expression of NFkB and IkB in islet cells of type 2 diabetic mellitus in rats. J. Tianjin Univ. Tradit. Chin. Med. 2010, 1:013.
39. Bernal-Mizrachi E., Fatrai S., Johnson J.D., Ohsugi M., Otani K., Han Z., Polonsky K.S., Permutt M.A. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet β-cells. J. Clin. Invest. 2004, 114:928-936.
40. Watanabe H., Saito H., Rychahou P.G., Uchida T., Evers B.M. Aging is associated with decreased pancreatic acinar cell regeneration and phosphatidylinositol 3-kinase/Akt activation. Gastroenterology 2005, 128:1391-1404.
41. Greer E.L., Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 2005, 24:7410-7425.
42. Barthel A., Schmoll D., Unterman T.G. FoxO proteins in insulin action and metabolism. Trends. Endocrin. Met. 2005, 16:183-189.
43. Birkenkamp K., Coffer P. Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem Soc. T. 2003, 31:292-297.